<DOC>
	<DOCNO>NCT00519363</DOCNO>
	<brief_summary>This open label pilot clinical trial cohort 15 Lupus patient Center Rheumatic Disease . Clinical evaluation laboratory test do eligible , patient receive oral atorvastatin , fix dose 40mg/day . Statins show induce clinical improvement rheumatoid arthritis patient , well lupus patient . The effectiveness note within 8 14 day , study 3 month . Clinical laboratory test check 1 3 month interval . We hypothesize statin drug ( atorvastatin ) slow progression SLE ( Systemic Lupus Erythematosus ) disease activity regulate TLR ( Toll-like receptor ) 2,4 , 9 pathway addition lower lipid level .</brief_summary>
	<brief_title>Statins Lupus : Effects Statins Clinical Lupus Parameters , Serological Markers Toll-like Receptors</brief_title>
	<detailed_description>Atorvastin ( Lipitor ) commonly use drug approve FDA treatment dyslipidemias . It relatively safe drug use periodic monitoring . Eligibility critera : - age 18-60 , female , marjority lupus patient female - least 4 ACR ( American College Rheumatology ) criterion SLE ( Systemic Lupus Erythematosus ) - Moderate Severe disease activity use approve SLEDAI ( Systemic Lupus Erythematosus Disease Activity Index ) - LDL cholesterol 100-190mg/dl Exclusion criterion : - Pregnancy , lactate want get pregnant - Unable take atorvastatin due allergy , liver disease , elevate liver function , myositis , elvated CPK ( creatine phosphakinase ) - already lipid lower therapy - already amiodarone , clarithromycin , cyclosporin , erythromycin , itraconazole , ketoconazole , nefazodone , verapamil , protease inhibitor , niacin , digoxin , k cholestyramine , colestipol - dianosis Myositis . Our goal colledt preliminary data see trend efficacy atorvastatin ameliorate SLE disease activity evaluate TLRs ( Toll-like receptor ) SLE patient . A p value &lt; 0.05 consider statistically significant . Our baseline subsequent visit , 80 % power detect minimum 34 % -39 % difference continous variable measure different interval .</detailed_description>
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Age 1860 , female least four ACR criterion SLE SLEDAI score &gt; 4 LDL cholesterol level 100190mg/dl Pregnant , lactating , want become pregnant unable take atorvastatin due allergy , liver disease , elevate lever function test , myositis , eleveated CPK already lipid lower therapy participate another lupus study drug : amiodarone , clarithromycin , clclosporine , erythromycin , itraconazole , ketoconazole , nefazodone , verapamil , protease inhibitor , niacin , digoxin , cholestryrmine , colestipol diagnosis myositis</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Lupus</keyword>
	<keyword>TLR 's</keyword>
	<keyword>Hyperlipidemia</keyword>
	<keyword>age eighteen sixty</keyword>
	<keyword>female SLE</keyword>
	<keyword>SLEDAI , great four</keyword>
	<keyword>LDL cholesterol elevate</keyword>
</DOC>